Rocket Pharma

New York, United States Founded: 2015 • Age: 11 yrs
Gene-modified cell therapies for rare diseases are developed.
Request Access

About Rocket Pharma

Rocket Pharma is a company based in New York (United States) founded in 2015.. Rocket Pharma has completed 1 acquisition, including Renovacor. Rocket Pharma operates in a competitive market with competitors including Moderna, BridgeBio, Spark Therapeutics, Alnylam and ATAI, among others.

  • Headquarter New York, United States
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Rocket Pharmaceuticals, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $5 M (USD), Post-IPO

    Dec 19, 2024

  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Rocket Pharma

Rocket Pharma is a publicly listed company on the NASDAQ with ticker symbol RCKT in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NASDAQ · Ticker: RCKT . Sector: Health technology · USA
People of Rocket Pharma
Headcount 10-50
Employee Profiles 122
Board Members and Advisors 1
Employee Profiles
People
Kinnari Patel
Chief Operating Officer & EVP, Development
People
Tavis B.
Associate Director, Regulatory Operations
People
Asad Vora
Senior Manager, Process Engineering
People
Michael Korn
Associate Director, QC - AAV

Unlock access to complete

Funding Insights of Rocket Pharma

  • Total Funding
  • Total Rounds 6
  • Last Round Post-IPO — $5.0M
  • First Round

    (15 Jan 2016)

  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2024 Amount Post-IPO - Rocket Pharma Valuation

investors

Aug, 2021 Amount Post-IPO - Rocket Pharma Valuation

investors

Nov, 2020 Amount Grant - Rocket Pharma Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Rocket Pharma

Rocket Pharma has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include RTW Investments, CIRM and Tavistock Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Life Sciences focused VC firm investing in the US
Founded Year Domain Location
Tavistock Group is engaged in global diversified investments.
Founded Year Domain Location
Healthcare startups are funded by this corporate-backed venture capital entity.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Rocket Pharma

Rocket Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Renovacor. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
BAG3-related gene therapies for cardiovascular and CNS disorders are developed.
2013
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Rocket Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Rocket Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Rocket Pharma

Rocket Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BridgeBio, Spark Therapeutics, Alnylam and ATAI, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
mRNA-based therapeutics for diseases including cancer and infections are developed.
domain founded_year HQ Location
Therapeutics for genetic diseases are developed through targeted interventions.
domain founded_year HQ Location
Gene therapies for rare diseases including retinal dystrophies are developed.
domain founded_year HQ Location
RNA interference-based therapeutics are developed for multiple disorders.
domain founded_year HQ Location
A biopharmaceutical company accelerating innovative mental health treatments.
domain founded_year HQ Location
An AI-enabled platform is developed for infectious disease treatment.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Rocket Pharma

Frequently Asked Questions about Rocket Pharma

When was Rocket Pharma founded?

Rocket Pharma was founded in 2015 and raised its 1st funding round 1 year after it was founded.

Where is Rocket Pharma located?

Rocket Pharma is headquartered in New York, United States. It is registered at New York, New York, United States.

What does Rocket Pharma do?

Rocket Pharma was founded in 2015 and is headquartered in New York, United States. Operations are centered in the biotechnology sector, where adeno-associated viral and lentiviral gene therapies are developed to address rare diseases. Specific therapies include RP-L102 for Fanconi anemia, RP-L201 for leukocyte adhesion deficiency, RP-L301 for pyruvate kinase deficiency, RP-L501 for Danon disease, and RP-A601 for PKP2-ACM, among others.

Who are the top competitors of Rocket Pharma?

Rocket Pharma's top competitors include Moderna, Spark Therapeutics and BridgeBio.

Is Rocket Pharma publicly traded?

Yes, Rocket Pharma is publicly traded on NASDAQ under the ticker symbol RCKT.

How many acquisitions has Rocket Pharma made?

Rocket Pharma has made 1 acquisition, including Renovacor.

Who are Rocket Pharma's investors?

Rocket Pharma has 5 investors. Key investors include RTW Investments, CIRM, Tavistock Group, LifeSci Venture Partners, and Cormorant.

What is Rocket Pharma's ticker symbol?

The ticker symbol of Rocket Pharma is RCKT on NASDAQ.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available